Lipid lowering agents and the endothelium: an update after 4 years

scientific article published on 01 January 2012

Lipid lowering agents and the endothelium: an update after 4 years is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2174/157016112798829742
P698PubMed publication ID22112353

P50authorVasilios G. AthyrosQ37837494
P2093author name stringKonstantinos Tziomalos
Dimitri P Mikhailidis
Asterios Karagiannis
P433issue1
P304page(s)33-41
P577publication date2012-01-01
P1433published inCurrent Vascular PharmacologyQ15751349
P1476titleLipid lowering agents and the endothelium: an update after 4 years
P478volume10

Reverse relations

cites work (P2860)
Q89687386Endocan and a novel score for dyslipidemia, oxidative stress and inflammation (DOI score) are independently correlated with glycated hemoglobin (HbA1c) in patients with prediabetes and type 2 diabetes
Q61796690Endocan as a marker of microvascular inflammation in kidney transplant recipients
Q37260183Plasma endocan level and prognosis of immunoglobulin A nephropathy
Q41779175Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia